About us
Pipeline
Therapeutic focus
Newsroom
Investors
Corporate governance
Career
Contact

About us
Pipeline
Therapeutic focus
Newsroom
Investors
Corporate governance
Career
Contact

Home
Events & Presentations
CEO interview on the shift to rare diseases with CS1 (Swedish)

CEO interview on the shift to rare diseases with CS1 (Swedish)

01 Oct 2020

Interview

CEO Sten R. Sörensen at BioStock

Cereno Scientific CEO Sten Sörensen being interviewed at BioStock

Watch here >

Sitemap

About us
Pipeline
Therapeutic focus
Corporate governance

Newsroom

Press releases
Events & presentations
Event calendar

Investors

Investment story
Share information
Share issues
Financial reports
Financial calendar

Contact

info@cerenoscientific.com

Copyright ©2016-2024 Cereno Scientific AB (publ). All rights reserved.

Privacy Policy

Congratulations!

Your subscription is now saved and you will recive an email to verify your email address and activate the subscription.

Sorry, there was something wrong with your request.

We could not save your subscriptions please go back and try again.